Using this approach and machine learning techniques, we found that multi-modal in vivo MRI and levels of plasma cytokines and urinary p75NTR-ecd may be effective pharmacodynamic biomarkers preclinically and have a high potential for translation to HD clinical trials, with combinations of these markers as the most powerful option. Here, NGFR is linked to Huntington disease.